Pathogenetic mechanisms in thyroid follicular-cell neoplasia

By T. Kondo, S. Ezzat, S. Asa. Nature Reviews. Cancer, 2006

929 citations recorded by the source corpus.

Subfields: Cell Biology, Endocrinology, Diabetes and Metabolism, Oncology

View Paper: https://www.semanticscholar.org/paper/8c0a8ee92c38ec616354d027bcb8430afe054cc0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cell Biology

1. F. van Roy
2. G. Berx

In Endocrinology, Diabetes and Metabolism

1. Y. Nikiforov
2. M. Nikiforova

In Oncology

1. Bert Vogelstein
2. Y. Nikiforov
3. M. Nikiforova
4. F. van Roy
5. G. Berx
6. R. Weinberg

Citations in the corpus

• MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. (2008, background): “Significant information has been accumulated on carcinogenic mutations in thyroid cancer (18).”
• Involvement of members of the cadherin superfamily in cancer. (2009, background): “Whether RET can be considered a cell adhesion receptor is undetermined, but its involvement in cancer is beyond doubt (reviewed by Kondo et al. 2006; Zbuk and Eng 2007).”
• American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer (2012, positive): “Other mutations, such as BRAF and RAS, are common in both well-differentiated thyroid cancer and ATCs and are likely to be early events in thyroid carcinogenesis that may predispose to tumor dedifferentiation (60,81).”
• Variation in cancer risk among tissues can be explained by the number of stem cell divisions (2015, background): “Only ~ 3% of these cancers are derived from parafollicular cells (C cells) (106-108), which are the cell of origin for medullary carcinomas.”